Jeff Yass’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,400
Closed -$314K 13716
2026
Q1
$314K Buy
9,400
+3,400
+57% +$126K ﹤0.01% 10763
2025
Q4
$209K Sell
6,000
-10,500
-64% -$387K ﹤0.01% 10778
2025
Q3
$616K Buy
+16,500
New +$571K ﹤0.01% 8487
2022
Q2
Sell
-15,700
Closed -$614K 13195
2022
Q1
$614K Buy
+15,700
New +$609K ﹤0.01% 8413
2021
Q4
Sell
-6,300
Closed -$298K 13336
2021
Q3
$298K Sell
6,300
-10,100
-62% -$472K ﹤0.01% 10613
2021
Q2
$760K Sell
16,400
-3,400
-17% -$154K ﹤0.01% 8523
2021
Q1
$869K Buy
+19,800
New +$899K ﹤0.01% 8092
2020
Q3
Sell
-11,700
Closed -$403K 10701
2020
Q2
$403K Buy
11,700
+3,700
+46% +$115K ﹤0.01% 7806
2020
Q1
$224K Sell
8,000
-1,000
-11% -$33.3K ﹤0.01% 8487
2019
Q4
$313K Buy
+9,000
New +$304K ﹤0.01% 7934
2018
Q4
Sell
-5,200
Closed -$200K 9215
2018
Q3
$200K Buy
+5,200
New +$191K ﹤0.01% 8221

Other funds holding FFTY

Jeff Yass's FFTY Position: Q2 2026 in Review

Jeff Yass increased its CapForce IBD 50 ETF (FFTY) stake by 39% in Q2 2026, buying an estimated $994K and bringing the position to 89,310 shares worth $3.89M. The position accounts for ﹤0.01% of the portfolio, ranked #5102.

Jeff Yass first reported a position in FFTY in Q4 2015 and has held it in 33 quarters since. The position peaked at $16.2M in Q3 2021. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

  • Jeff Yass held 89,310 shares of CapForce IBD 50 ETF worth $3.89M as of Q2 2026.
  • Jeff Yass bought 25,243 CapForce IBD 50 ETF shares in Q2 2026, an estimated $994K.
  • CapForce IBD 50 ETF made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5102 holding.
  • Jeff Yass first reported a position in CapForce IBD 50 ETF in Q4 2015 and has held it in 33 quarters since.
  • Jeff Yass's CapForce IBD 50 ETF position peaked at $16.2M in Q3 2021.
  • 33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.